The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ellison Mark Jason Heath since 2019.
This trader's CIK number is 1781982.
At the time of last reporting, Ellison Mark Jason Heath was the Chief Development Officer of Opiant Pharmaceuticals, Inc.. (stock ticker symbol OPNT).
Also see all insider trading activities at Opiant Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | OPNT | 0 | $0 | 610 | $12,358 | 0 | $0 |
| 2019 | OPNT | 0 | $0 | 0 | $0 | 30,000 | $300,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-27 | OPNT | Sale | 610 | 20.26 | 12,358 |
| 2019-07-29 | OPNT | Option Ex | 30,000 | 10.00 | 300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ellison Mark Jason Heath (Chief Development Officer of Opiant Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.